London & Capital Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,572
Closed -$512K 243
2025
Q4
$512K Sell
10,572
-15,538
-60% -$770K 0.01% 163
2025
Q3
$1.23M Sell
26,110
-54,845
-68% -$2.65M 0.09% 58
2025
Q2
$3.91M Sell
80,955
-187,997
-70% -$9.61M 0.3% 49
2025
Q1
$14.9M Sell
268,952
-20,123
-7% -$1.09M 1.28% 27
2024
Q4
$13.9M Buy
289,075
+9,059
+3% +$461K 1.19% 42
2024
Q3
$16.1M Buy
280,016
+12,027
+4% +$649K 1.28% 36
2024
Q2
$13M Buy
267,989
+17,914
+7% +$864K 1.1% 39
2024
Q1
$12.2M Buy
250,075
+37,542
+18% +$1.83M 0.93% 37
2023
Q4
$10.6M Buy
212,533
+12,089
+6% +$591K 0.89% 37
2023
Q3
$10.8M Buy
200,444
+7,752
+4% +$413K 0.98% 33
2023
Q2
$10.4M Sell
192,692
-47,827
-20% -$2.57M 1.03% 34
2023
Q1
$13.1M Sell
240,519
-17,001
-7% -$827K 1.23% 34
2022
Q4
$12.5M Buy
257,520
+1,601
+0.6% +$70.3K 1.15% 35
2022
Q3
$9.73M Buy
255,919
+14,619
+6% +$651K 0.91% 37
2022
Q2
$12.1M Buy
241,300
+32,444
+16% +$1.72M 0.96% 36
2022
Q1
$10.7M Buy
208,856
+25,754
+14% +$1.33M 0.79% 36
2021
Q4
$9.17M Buy
183,102
+36,461
+25% +$1.8M 0.56% 41
2021
Q3
$7.07M Buy
146,641
+15,811
+12% +$804K 0.51% 43
2021
Q2
$6.89M Buy
130,830
+19,395
+17% +$1.01M 0.56% 44
2021
Q1
$5.51M Buy
111,435
+18,874
+20% +$907K 0.51% 48
2020
Q4
$4.5M Buy
92,561
+28,201
+44% +$1.39M 0.5% 41
2020
Q3
$3.23M Buy
64,360
+15,995
+33% +$823K 0.43% 39
2020
Q2
$2.47M Buy
48,365
+27,320
+130% +$1.33M 0.43% 35
2020
Q1
$920K Buy
+21,045
New +$1.01M 0.22% 43

Other funds holding SNY

London & Capital Asset Management's SNY Position: Q1 2026 in Review

London & Capital Asset Management sold out of Sanofi (SNY) in Q1 2026, closing a stake of 10,572 shares — an estimated $512K sold.

London & Capital Asset Management first reported a position in SNY in Q1 2020 and held it in 24 quarters. The position peaked at $16.1M in Q3 2024. 739 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • London & Capital Asset Management reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • London & Capital Asset Management sold 10,572 Sanofi shares in Q1 2026, an estimated $512K.
  • London & Capital Asset Management first reported a position in Sanofi in Q1 2020 and held it in 24 quarters.
  • London & Capital Asset Management's Sanofi position peaked at $16.1M in Q3 2024.
  • 739 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on London & Capital Asset Management's 13F filing for Q1 2026, filed 15 May 2026.